The report titled “Indonesia Clinical Laboratory Market Outlook to 2026F- Driven by Current Shortage, Widening Customer Base and Increasing Corporate Requirements for Clinical Testing” provides a comprehensive analysis of Clinical Laboratory Market in Indonesia. The report focuses on overall market size in terms of revenue generated by laboratories; Indonesia clinical laboratory market segmentation by Type of Independent Labs, type of payer, type of customers, types of tests, segmentation based on region and private hospitals. The report also covers the overall comparative landscape, trends and growth drivers, issues and challenge and government regulations. The report concludes with future projections and analyst recommendations highlighting the major opportunities and cautions.
Request For Sample Report @ https://www.kenresearch.com/sample-report.php?Frmdetails=NTI0MDQ5
Market Overview and Size
Indonesia Clinical Lab market was observed to grow with an
augmenting growth rate in the review period 2016-2021. The Indonesia Clinical
Lab market in terms of Revenue has increased at a positive CAGR of 11.5% during
the review period 2016-2021. The growth was supported by increase in healthcare
spending by aging population, expanding health insurance, growth in
non-communicable disease and chronic diseases, rising disposable Income.
Market Segmentation of
Data Center Industry
By Type of Labs: Clinical Laboratories can be
recognized as Independent Labs, Private Hospital Labs and Public Hospital Labs.
Public Hospital Labs have a majority in the Indonesian market followed by
Private Hospital Labs.
By Number of Labs: The labs can be recognized as public
or private labs basis their ownership. Private Labs dominate the market in
Indonesia.
By Type of Private
Independent Labs: In
Indonesia, organized labs dominated the market share followed by unorganized
labs. Majority of the organized labs are located in Java and Jakarta. This has
been facilitated by increase in expenditure on health services, as people have
become more health conscious.
By Type of Payer: Corporates have accounted for the
largest share of the number of tests in Indonesia. As the growing Indonesian
workforce has led to an increase in corporate clients for pre-employment checks
and annual health checks, more companies are engaging with private medical
labs.
By Type of Consumer
(Basis Number of Tests): Majority of the patients who are consumer to these laboratories come
through doctor referrals with majority market share based on the number of
tests. Walk-ins and corporate clients respectively follow this.
By Type of Tests: On the basis of type of tests the
market is split between Routine, Esoteric and Non-laboratory tests. The most
popular in the market are Routine tests. The non-laboratory tests account for a
relatively small share of lab tests due to the additional licenses required to
carry them out. Thus, laboratories are reluctant to do those tests.
By Type of Routine
Tests: The routine
tests have different categories of tests. The leader in this category is CBC
followed by Basic Metabolic Panel.
By Esoteric tests: The esoteric tests have different
categories of tests. The leader in this category is endocrine followed by
infectious disease.
By Region: Java, Jakarta and Bali have high rate of urbanization and more
affluent population, which has created greater access and demand for private
clinical laboratory testing services.
By Private Hospital
Labs: Private
hospitals either have their own in-house labs or have a tie-up with a third
party lab to accommodate their labs. In Indonesia in-house laboratories have a
majority.
Competitive Landscape
The market is highly concentrated with the top private
independent players being Prodia and Diagnos. Market is dominated by Prodia
(PRDA). Kimia farma is the 2nd major player and Bio medika is the least
contributor. CITO was designated by the Ministry of Health to be one of the
laboratories for examining the coronavirus. This helped to be recognized across
the region and thereby sustain footprints in the market. To capture the shift,
industry leaders have started to implement initiatives such as retailer
partnering, offering home testing, and enhancing engagement with patients
through digital presence.
Future Outlook and
Projections
Over the forecast period 2022-2026F, the Indonesia Clinical
Lab Market Revenue is further anticipated to increase by year 2026F, thus
showcasing a CAGR of 12.5%. It is expected that the implementation of JKN will
increase the demand for laboratory services. This will lead the public
hospitals to refer samples to private independent laboratories for clinical
testing, resulting in the growth of external referrals for private independent
laboratories. Players, Investing to increase its testing capabilities and has
adopted several advanced tests and technologies introduced in the global
market, particularly specialized tests. Further, the major private independent
laboratories chains are expected to undergo geographic expansion beyond key
cities into underdeveloped areas. This will further lead to increase in market
share in the overall Indonesia clinical laboratory market.
Key Segments Covered of
Clinical Laboratory
By Type of Labs
Independent Labs
Private Hospital Labs
Public Hospital Labs
By Number of Labs
Private Labs
Public Labs
By Type of Private
Independent Labs:
Organised
Unorganised
By Type of payor:
Corporates
Out-Of-Pocket
Private Insurance
BPJS Badan Penyelenggara Jaminan Sosial (Social Insurance
Administration Organization)
By Type of Customer:
Doctor Referral
Corporates
Walk-Ins
External referrals
Online Referrals
By Type of Tests:
Routine
Esoteric
Non-Laboratory
By Type of routine
tests:
CBC
Basic Metabolic Panel
A1C
Others
By Type of Esoteric
Tests
Endocrine
Infectious disease
Allergic Disease
Oncology
Others
By Private Hospital
Labs
In-House
Third Party
By Region
Greater Jakarta
West Java
East Java, Bali, Nusa
Aceh and North Sumatera
Central Java
Central Sumatera
Sulawesi and Maluku
Kalimantran
Others
Key Target Audience
Clinical Laboratory companies
Organised Clinical Laboratories
Unorganised Clinical Laboratories
Private Hospitals
Private Equity and Venture Capitalist
Industry Associations
Technology providers
Time Period Captured in
the Report:
Historical Period – 2016-2021
Forecast Period – 2021-2026
Companies Covered:
Organised Laboratory
Companies:
Prodia
Diagnos
Pathlab
Pramita
Ultra Medica
Kimia Farma
Prima Medika
Cito
Parahita
ABC Labs
Bio Medika
Key Topics Covered in
the Report
Overview of Indonesia Clinical Laboratory Market
Ecosystem of Major Entities in Indonesia Clinical Laboratory
Market
Business Cycle and Genesis of Indonesia Clinical Laboratory
Market
Indonesia Clinical Laboratory Market Size, 2016-2021
Indonesia Clinical Laboratory Market Segmentations
Competition Analysis: Indonesia Clinical Laboratory Companies
SWOT Analysis in Indonesia Clinical Laboratory Market
Growth Drivers and Restraints in Indonesia Clinical
Laboratory Market
Technological Advancements in Indonesia Clinical Laboratory
Market
Impact of COVID19 in Malaysia Property Classified Market
Key Trends in Indonesia Clinical Laboratory Market
Outlook and Future Projections for Indonesia Clinical
Laboratory Market
Recommendations / Success Factors
Research Methodology
Appendix
For More Information on the Research
Report, refer to below links: -
Indonesia
Clinical Laboratory Market
Related Reports by Ken Research
Contact Us:-
Ken
Research
Ankur
Gupta, Head Marketing & Communications
+91-9015378249
Follow Us
